Lexology February 13, 2019
In the past few weeks, divisions of the U.S. Department of Health and Human Services (“HHS”) have taken three separate actions that, while individually distinct, collectively reflect continuing interest in facilitating high-value care delivery that goes far beyond traditional models. The actions are:
On January 18, 2019, the Center for Medicare and Medicaid Innovation (“CMMI”) announced an expansion to its Medicare Advantage (“MA”) Value-Based Insurance Design (“VBID”) model, with wellness and health care planning as one component of the expansion.
On January 29, 2019, HHS’s Office of Inspector General (“OIG”) issued an advisory opinion permitting a drug manufacturer to offer medication-adjacent technology to patients.
On January 30, 2019, the Centers for Medicare & Medicaid Services (“CMS”) issued Part II of...